Results 111 to 120 of about 75,728 (168)

Molecular characterisation of ret tyrosine kinase signalling [PDF]

, 2005
Arighi, Elena
core  

Non-receptor tyrosine kinase c-Abl downstream of C-type lectin receptors regulates innate antifungal immunity through c-Cbl/MAPK pathway. [PDF]

Infect Immun
Ma S-J, Xie K-F, Duan J-L, Wang X-L, Yang Y-H, Wang Y.   +5 more
europepmc   +1 more source

JUNB and JUND in Urological Cancers: A Literature Review. [PDF]

Curr Issues Mol Biol
Kalampounias G, Androutsopoulou T, Katsoris P.   +2 more
europepmc   +1 more source

<i>RGS4</i> in gastric cancer: A multifaceted regulator of focal-adhesion-kinase -phosphatidyl-inositol-3-kinase - protein-kinase-B signaling and epithelial-mesenchymal transition beyond tumor progression. [PDF]

World J Gastroenterol
Yang Y, Chen WM.
europepmc   +1 more source

ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation. [PDF]

Sci Prog
Chen W, Chen X, Wang L, Qu Y, Zhao J, Sun H.   +5 more
europepmc   +1 more source

FOS and JUN regulate oxidative stress and steroidogenesis in human aldosterone-producing adenomas. [PDF]

Redox Biol
Wei J, Duregon E, Papotti MG, Knösel T, Bidlingmaier M, Sbiera S, Reincke M, Williams TA.   +7 more
europepmc   +1 more source

Plasma proteomic profiling and molecular clustering reveal immune-defined prognostic subtypes in lung adenocarcinoma. [PDF]

Int J Cancer
Neogi U, Ambikan AT, Turkowski K, Schneider MA, Beutgen VM, Graumann J, Winter H, Bartkuhn M, Seeger W, Pullamsetti SS, Savai R.   +10 more
europepmc   +1 more source

Network pharmacology analysis and in vitro experimental validation of liriodenine against non-small cell lung cancer. [PDF]

BMC Cancer
Yang J, Sun Y, Liang F, Shen Z, Zhou Y, Zhu J, Sun W, Xia Y.   +7 more
europepmc   +1 more source

Regulatory dynamics of IFI44L in systemic lupus erythematosus: the interplay of type I interferon and c-Jun. [PDF]

Lupus Sci Med
Wang Y, Yang M, Ma H, Ma X, Huo Z, Ma Z, Dang J.   +6 more
europepmc   +1 more source

Ginkgo biloba extract suppresses hepatocellular carcinoma progression by inhibiting the recruitment of myeloid-derived suppressor cells through reduced CXCL1 secretion via SRC downregulation. [PDF]

Front Immunol
Xu Z, Liang S, You X, Jin A, Mao L, Zhong F, Yuan T, He J, Yi B, Li M, Tu Q.   +10 more
europepmc   +1 more source